NCT04104698 Cognitive, Psychological and Electrophysiological Attributes to Suicide Among Depressed Patients Status UNKNOWN Phase N/A
NCT04091971 Ketamine Treatment Effects on Synaptic Plasticity in Depression Status COMPLETED Phase PHASE4
NCT04088448 The Antidiabetic Metformin as a Novel Adjunct to Antidepressants in Major Depressive Disorder Patients Status COMPLETED Phase PHASE1/PHASE2
NCT04082806 Memory Enhancement by Gamma-hydroxybutyrate vs. Trazodone in Major Depressive Disorder. Status COMPLETED Phase PHASE2
NCT04069819 The Phosphodiesterase-3 Inhibitor Cilostazol as an Adjunctive to Antidepressants in Patients With Major Depressive Disorder. Status COMPLETED Phase NA
NCT04061148 Near Infrared Spectroscopy (NIRS) for Assessment of Depression Status RECRUITING Phase NA
NCT04055181 Influence of rTMS on Symptoms and Cognitive Function in Patients With Psychiatric Disorders Status COMPLETED Phase NA
NCT04041284 A Study to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of Migraine in Patients With Major Depressive Disorder Status COMPLETED Phase PHASE4
NCT04039022 Open-Label Safety Study of AXS-05 in Subjects With Depression Status COMPLETED Phase PHASE3
NCT04037111 Clinical Study of Escitalopram Oxalate Combined With taVNS in Depression and Concomitant Inflammatory Symptoms Status UNKNOWN Phase NA
NCT04032301 Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans Status COMPLETED Phase PHASE1
NCT04032015 rTMS Study in Depression to Evaluate the Relationship Between Brain Plasticity and Clinical Outcome Status WITHDRAWN Phase NA
NCT04031157 Controlled Study to Evaluate the Safety and Efficacy of the Predictix Antidepressant Clinician Support Tool Status UNKNOWN Phase NA
NCT04019704 A Trial of AXS-05 in Patients With Major Depressive Disorder Status COMPLETED Phase PHASE3